If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
18.00    0.00 (0.00%)
Bid:
17.00
Ask:
19.00
Spread: 2.00 (11.765%)
Market Cap: £16.31m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

Form 8 (OPD) The Mission Group plc

28 May 2024 07:00

RNS Number : 7213P
Brave Bison Group PLC
28 May 2024
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Brave Bison Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

The Mission Group plc

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

24 May 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

Brave Bison Group plc

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary 1p

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

Company name/director name

Number of ordinary shares held

Percentage of total issued share capital

Ultimate controlling party (if applicable)

Philippa Kate Norridge

334

0.00%

N/A

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

28 May 2024

Contact name:

Philippa Kate Norridge

Telephone number:

02072537000

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEESEUFLDELSELI
Date   Source Headline
15th Jun 20261:00 pmRNSResult of AGM
15th Jun 20267:00 amRNSAGM Trading Update
4th Jun 20267:00 amRNSNotice of AGM and Posting of Annual Report
21st May 202611:46 amRNSDirector/PDMR Shareholding
1st May 20262:45 pmRNSHolding(s) in Company
28th Apr 202611:00 amRNSHolding(s) in Company
27th Mar 20264:50 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSFinal Results
20th Mar 202612:00 pmRNSNotice of Investor Presentation
18th Feb 20267:00 amRNSGrowth Share Scheme
13th Jan 20267:00 amRNSBoard Changes
13th Jan 20267:00 amRNSFull Year Trading Update
17th Oct 20257:00 amRNSDirectorate Change
10th Oct 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2025
12th Sep 20257:00 amRNSBOARD CHANGES
22nd Aug 20257:00 amRNSNOTICE OF RESULTS AND INVESTOR PRESENTATION
12th Aug 20254:22 pmRNSHolding(s) in Company
6th Aug 20256:24 pmRNSHolding(s) in Company
24th Jul 20257:00 amRNSTrading Update
1st Jul 20257:00 amRNSMISSION Group plc appoints John Carey as new CEO
16th Jun 20251:19 pmRNSResult of AGM
16th Jun 20257:00 amRNSAGM Trading Update
11th Jun 202511:44 amRNSNotice of AGM and Posting of Annual Report
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 202510:16 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSFINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024
10th Mar 20257:00 amRNSInvestor Presentation
17th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20258:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNS2024 Full Year Trading Update
13th Jan 20259:30 amRNSHolding(s) in Company
10th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20253:47 pmRNSHolding(s) in Company
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSDirectorate Change
2nd Jan 20257:00 amRNSShare buyback programme
2nd Jan 20257:00 amRNSDisposal and Capital Allocation Update
21st Nov 20247:00 amRNSDirectorate Change
24th Sep 20247:00 amRNSINTERIM RESULTS FOR THE SIX MONTHS TO 30 JUNE 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.